The first U.S. trials in people put CRISPR to the test in 2019

When it was unveiled in 2012, people had great hopes that the gene editor CRISPR/Cas9 could treat or even cure hundreds to thousands of genetic diseases. This year, researchers in the United States began testing the gene editor in people, a crucial first step in determining whether the technology can fulfill its medical promise.
Read more: https://www.sciencenews.org/article/crispr-gene-editor-human-clinical-trials-top-science-stories-2019-yir?source=Snapzu